Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.1350
-0.0050 (-3.57%)
At close: Mar 20, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 537.84 thousand as of March 20, 2026. Its market cap has decreased by -80.37% in one year.
Market Cap
537.84K
Enterprise Value
90.84K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 537.84K, an increase of 452.44%. That is a compound annual growth rate of 18.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 537.84K | -6.90% |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gemina Laboratories | 3.06M |
| Algernon Health | 2.17M |
| Rakovina Therapeutics | 2.11M |
| Appili Therapeutics | 1.99M |
| Universal Ibogaine | 1.56M |
| Entheon Biomedical | 1.39M |
| Waverley Pharma | 810.00K |
| ChitogenX | 415.65K |